James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 18,784 shares at $21.72 ($408K) on 2016-12-30, disclosed to the SEC on 2017-01-04.
Open-market purchase of $408k RETA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.72 | 9,392 | $204K | 50.0% |
| 2 | $21.72 | 9,392 | $204K | 50.0% |
| Total | $21.72 avg | 18,784 | $408K | 100% |
| Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |